Cornerstone Wealth Group LLC Invests $4.03 Million in Rxo Inc $RXO

Cornerstone Wealth Group LLC purchased a new position in shares of Rxo Inc (NYSE:RXOFree Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 261,768 shares of the company’s stock, valued at approximately $4,026,000. Cornerstone Wealth Group LLC owned about 0.16% of RXO at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Orbis Allan Gray Ltd boosted its stake in RXO by 3.8% in the second quarter. Orbis Allan Gray Ltd now owns 31,375,221 shares of the company’s stock worth $493,218,000 after purchasing an additional 1,142,710 shares in the last quarter. Norges Bank acquired a new stake in shares of RXO in the second quarter valued at approximately $16,949,000. Owls Nest Partners IA LLC bought a new position in RXO in the 2nd quarter worth approximately $9,287,000. Frontier Capital Management Co. LLC lifted its holdings in RXO by 39.6% during the 2nd quarter. Frontier Capital Management Co. LLC now owns 1,801,187 shares of the company’s stock worth $28,315,000 after buying an additional 511,036 shares in the last quarter. Finally, Marshall Wace LLP bought a new position in RXO in the 2nd quarter valued at $7,124,000. Institutional investors own 92.73% of the company’s stock.

Analyst Upgrades and Downgrades

RXO has been the subject of a number of recent research reports. Benchmark restated a “hold” rating on shares of RXO in a research report on Thursday, January 15th. Wall Street Zen cut RXO from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Stifel Nicolaus upped their target price on shares of RXO from $15.00 to $16.00 and gave the company a “hold” rating in a research report on Tuesday, December 16th. Barclays lowered their price target on shares of RXO from $17.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, November 7th. Finally, UBS Group dropped their price target on shares of RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Four research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat, RXO currently has a consensus rating of “Hold” and a consensus target price of $16.14.

Check Out Our Latest Stock Analysis on RXO

RXO Price Performance

Shares of RXO opened at $14.65 on Wednesday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.24. Rxo Inc has a 1 year low of $10.43 and a 1 year high of $26.92. The stock has a market cap of $2.40 billion, a P/E ratio of -34.06, a price-to-earnings-growth ratio of 7.32 and a beta of 1.74. The stock’s 50-day moving average price is $13.42 and its two-hundred day moving average price is $15.27.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). RXO had a negative net margin of 1.25% and a positive return on equity of 0.88%. The company had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same period last year, the company earned $0.05 earnings per share. The business’s revenue was up 34.6% compared to the same quarter last year. On average, equities analysts predict that Rxo Inc will post 0.31 earnings per share for the current year.

Insider Buying and Selling at RXO

In other news, Director Troy A. Cooper bought 8,317 shares of the business’s stock in a transaction on Thursday, November 20th. The shares were bought at an average cost of $10.61 per share, for a total transaction of $88,243.37. Following the completion of the acquisition, the director owned 275,416 shares in the company, valued at approximately $2,922,163.76. This trade represents a 3.11% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Andrew M. Wilkerson purchased 7,775 shares of RXO stock in a transaction dated Monday, November 10th. The shares were purchased at an average cost of $12.88 per share, for a total transaction of $100,142.00. Following the completion of the transaction, the chief executive officer owned 7,775 shares of the company’s stock, valued at approximately $100,142. This represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders bought 40,250 shares of company stock valued at $488,875. Corporate insiders own 1.48% of the company’s stock.

RXO Profile

(Free Report)

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.

Featured Stories

Want to see what other hedge funds are holding RXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rxo Inc (NYSE:RXOFree Report).

Institutional Ownership by Quarter for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.